| Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder (NCT06261060) | M.D. Anderson Cancer Center | 2024-06-20 |
| SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy (NCT05990192) | Institute of Cancer Research, United Kingdom | 2024-06-20 |
| Comparing the Effect of Different Intracanal Dressing on Failed Root Canal Treated Cases on Periapical Healing (NCT06342830) | Ain Shams University | 2024-06-20 |
| Adebrelimab + Apatinib in SCLC Maintenance Therapy (NCT06475209) | Tang-Du Hospital | 2024-06-20 |
| Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema (NCT05897424) | Sanofi | 2024-06-20 |
| TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination (NCT06478537) | Peking Union Medical College Hospital | 2024-06-20 |
| TYK2 Inhibition in Paradoxical Psoriasis (NCT06281106) | Prof Curdin Conrad | 2024-06-20 |
| Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer (NCT06791083) | First Affiliated Hospital of Fujian Medical University | 2024-06-20 |
| A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) (NCT06428409) | Merck Sharp & Dohme LLC | 2024-06-20 |
| Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer (NCT06480110) | Rigshospitalet, Denmark | 2024-06-20 |
| A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer (NCT06474468) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2024-06-20 |
| A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma (NCT06115135) | Oncotherapeutics | 2024-06-20 |
| First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients (NCT06313970) | Fudan University | 2024-06-20 |
| Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma. (NCT06454968) | Peking Union Medical College Hospital | 2024-06-20 |
| A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) (NCT06389799) | Lund University Hospital | 2024-06-20 |
| ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency (NCT06462547) | Inozyme Pharma | 2024-06-19 |
| Trial of JYB1904 in Patients With Allergic Asthma (NCT06438757) | Jemincare | 2024-06-19 |
| Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1 (NCT06131983) | Sarepta Therapeutics, Inc. | 2024-06-19 |
| A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus (NCT06106906) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-06-19 |
| A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC (NCT06598046) | Henan Cancer Hospital | 2024-06-19 |
| Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients (NCT06505369) | North Estonia Medical Centre | 2024-06-19 |
| RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients (NCT06341400) | Zhujiang Hospital | 2024-06-19 |
| Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction (NCT06469060) | Shanghai Chest Hospital | 2024-06-19 |
| Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis (NCT06309355) | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 2024-06-19 |
| Safety and Efficacy Predimenol for Headache (NCT06558006) | Dexa Medica Group | 2024-06-19 |
| A Trial of Lu AG13909 in Adult Participants With Cushing's Disease (NCT06471829) | H. Lundbeck A/S | 2024-06-19 |
| Novel Augmentation of DAOIB and Antioxidant for Early Dementia (NCT06467539) | Chang Gung Memorial Hospital | 2024-06-19 |
| Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma (NCT06124976) | Peter Black | 2024-06-19 |
| A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer (NCT06445400) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-06-19 |
| Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC. (NCT06452602) | Tianjin Medical University Cancer Institute and Hospital | 2024-06-19 |
| HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study (NCT06482008) | Sun Yat-sen University | 2024-06-19 |
| Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma (NCT06470217) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2024-06-19 |
| A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD) (NCT06389877) | Beam Therapeutics Inc. | 2024-06-19 |
| A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors (NCT06468358) | L & L Bio Co., Ltd., Ningbo, China | 2024-06-19 |
| GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma (NCT06455410) | Sun Yat-sen University | 2024-06-18 |
| MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (NCT05564390) | National Cancer Institute (NCI) | 2024-06-18 |
| PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer (NCT06083857) | M.D. Anderson Cancer Center | 2024-06-18 |
| CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies (NCT06316856) | Beijing GoBroad Hospital | 2024-06-18 |
| Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting. (NCT06087263) | M.D. Anderson Cancer Center | 2024-06-18 |
| SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases (NCT05775146) | AHS Cancer Control Alberta | 2024-06-18 |
| Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL (NCT06500273) | Allogene Therapeutics | 2024-06-18 |
| CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma (NCT06482294) | Università degli Studi di Ferrara | 2024-06-18 |
| FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer (NCT06563986) | UMC Utrecht | 2024-06-18 |
| Adolescent Chatbot (NCT07094503) | Washington University School of Medicine | 2024-06-18 |
| Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1 (NCT06435026) | University of North Carolina, Chapel Hill | 2024-06-18 |
| Fluzoparib Neoadjuvant Therapy for Ovarian Cancer (NCT06541314) | Qilu Hospital of Shandong University | 2024-06-18 |
| A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors (NCT06399757) | Apollo Therapeutics Ltd | 2024-06-18 |
| Essential Amino Acid Supplementation for Femoral Fragility Fractures (NCT06050668) | Michael C Willey | 2024-06-17 |
| Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis (NCT06207370) | 60 Degrees Pharmaceuticals LLC | 2024-06-17 |
| Implantation of Cartilage Mini-grafts Made From Donor Cells to Treat Chondral Lesions of the Knee (NCT06897111) | Vanarix SA | 2024-06-17 |
| Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection (NCT06510582) | The Cooper Health System | 2024-06-17 |
| Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma (NCT06427239) | Fudan University | 2024-06-17 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients (NCT06389682) | Norroy Bioscience Co., LTD | 2024-06-17 |
| A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors (NCT06158516) | Changhai Hospital | 2024-06-17 |
| Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (NCT06468670) | Fujian Cancer Hospital | 2024-06-17 |
| A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer (NCT06498518) | Karen Carty | 2024-06-17 |
| Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment (NCT06323837) | Washington State University | 2024-06-17 |
| Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC (NCT06263543) | Reshma L. Mahtani, D.O. | 2024-06-17 |
| Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) (NCT06385730) | Shanghai Chest Hospital | 2024-06-17 |
| Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over (NCT06569823) | Dynavax Technologies Corporation | 2024-06-17 |
| Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma (NCT06468644) | Fujian Cancer Hospital | 2024-06-17 |
| A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations (NCT06378593) | 3H (Suzhou) Pharmaceuticals Co., Ltd. | 2024-06-17 |
| Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs (NCT06475443) | Henan Cancer Hospital | 2024-06-15 |
| The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries. (NCT06427707) | Ain Shams University | 2024-06-15 |
| Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer (NCT06454448) | Tianjin Medical University Cancer Institute and Hospital | 2024-06-15 |
| Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases (NCT06462079) | Guangzhou Medical University | 2024-06-15 |
| Epsom Salt Compresses to Relieve Perineal for Postpartum Care: a Clinical Trial (NCT06393608) | Antoine Roger | 2024-06-15 |
| Transcutaneous Spinal Cord Stimulation for Upper Extremity Function (NCT06596369) | University of Alberta | 2024-06-15 |
| A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery (NCT06504147) | Oncoinvent Solutions AS | 2024-06-15 |
| Effects of Platelet-Rich Fibrin on Postoperative Outcomes Following Nasosinusal Surgery (NCT07645053) | Hospital Edmundo Vasconcelos | 2024-06-15 |
| Assessment of the Efficacy of Scorpion Antivenom Therapy in a Dose-response Manner, in Patients With Scorpionism (NCT06333834) | Selene Guadalupe Huerta Olvera | 2024-06-15 |
| A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors (NCT06394713) | Qilu Pharmaceutical Co., Ltd. | 2024-06-15 |
| In-office Repair of Chronic Tympanic Membrane Perforations (NCT06448039) | D. Bradley Welling, MD, PhD | 2024-06-15 |
| Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder (NCT06206512) | Sarfez Pharmaceuticals, Inc. | 2024-06-15 |
| Dronabinol as an Adjunct for Reducing Pain (NCT06454669) | Christopher D. Verrico | 2024-06-15 |
| Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD (NCT06418477) | Peking University People's Hospital | 2024-06-15 |
| Ketamine for OUD and Suicidal Ideation in the ED (NCT06111339) | Brigham and Women's Hospital | 2024-06-14 |
| Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level (NCT06503172) | Taipei Veterans General Hospital, Taiwan | 2024-06-14 |
| A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis (NCT06149559) | UCB Biopharma SRL | 2024-06-14 |
| PTCy and ATG for MSD and MUD Transplants (NCT06299462) | Instituto Nacional de Cancer, Brazil | 2024-06-14 |
| To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2 (NCT06378242) | RemeGen Co., Ltd. | 2024-06-14 |
| RE104 Safety and Efficacy Study in Postpartum Depression (NCT06342310) | Reunion Neuroscience Inc | 2024-06-14 |
| Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06461910) | Zekuan Xu | 2024-06-14 |
| Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures (NCT06084689) | Institut Bergonié | 2024-06-14 |
| CBD for Knee Osteoarthritis (NCT06414473) | University of Florida | 2024-06-14 |
| A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients (NCT06186076) | Therapex Co., Ltd | 2024-06-14 |
| Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse (NCT06271057) | The Lymphoma Academic Research Organisation | 2024-06-14 |
| Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma (NCT06249191) | OHSU Knight Cancer Institute | 2024-06-13 |
| Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008) (NCT06322108) | Immune Oncology Research Institute | 2024-06-13 |
| Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer (NCT06205836) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-06-13 |
| Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts (NCT06488898) | Instituto de Investigación Hospital Universitario La Paz | 2024-06-13 |
| Microbiome Alterations With Xylitol (MAX) in Pregnancy (NCT06329596) | Baylor College of Medicine | 2024-06-13 |
| Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER) (NCT06228066) | National Cancer Institute (NCI) | 2024-06-13 |
| Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma (NCT06532539) | Shandong Cancer Hospital and Institute | 2024-06-13 |
| Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy (NCT06478862) | Lipomedix Pharmaceuticals Inc. | 2024-06-13 |
| A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) (NCT06557265) | Nkarta, Inc. | 2024-06-13 |
| FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum (NCT06393816) | Centre Leon Berard | 2024-06-13 |
| A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH (NCT06410924) | Neuraly, Inc. | 2024-06-13 |
| A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer (NCT06437509) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-06-13 |
| NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial (NCT06342037) | The Netherlands Cancer Institute | 2024-06-12 |